Top Cardiology Trials of 2021


Manage episode 314898613 series 3082824
By Medscape Podcasts. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

Drs Harrington and Gibson provide their annual roundup of what they consider the key cardiovascular trials of 2021. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit

This podcast is intended for US healthcare professionals only.

To read a full transcript of this episode or to comment please visit:

Antiplatelet Therapy

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI

Aspirin Versus Clopidogrel for Chronic Maintenance Monotherapy After Percutaneous Coronary Intervention (HOST-EXAM): An Investigator-Initiated, Prospective, Randomised, Open-Label, Multicentre Trial

SGLT2 Inhibitors and GLP-1 Agonists

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Cardiac Surgery and PCI

Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke

Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation

Fractional Flow Reserve–Guided PCI as Compared with Coronary Bypass Surgery

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology

Questions or feedback? Please contact

47 episodes